Koyfin Home > Directory > Health Care > Acceleron Pharma > EV / Sales (ntm)

Acceleron Pharma EV / Sales (ntm) Chart (XLRN)

Acceleron Pharma annual/quarterly EV / Sales (ntm) from 2013 to 2020.
  • Acceleron Pharma EV / Sales (ntm) for the quarter ending September 09, 2020 was 49.95 a 7.55% increase of 3.77 year over year
  • Acceleron Pharma EV / Sales (ntm) for the last 12 months ending September 09, 2020 was 49.95 a 7.55% increase of 3.77 year over year
  • Acceleron Pharma Annual EV / Sales (ntm) for 2020 was 49.95 a 3.85% increase of 1.92 from 2019
  • Acceleron Pharma Annual EV / Sales (ntm) for 2020 was 48.03 a 0.83% increase of 0.40 from 2019
  • Acceleron Pharma Annual EV / Sales (ntm) for 2020 was 47.63 a 3.05% increase of 1.45 from 2019
Other Valuation Metrics:
  • Acceleron Pharma Market Cap for the quarter ending March 03, 2018 was $1,776m a 33.91% increase of 602m year over year
  • Acceleron Pharma Price / Book for the quarter ending March 03, 2018 was 4.85 a -16.20% decrease of -0.78 year over year
  • Acceleron Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,499m a 31.12% increase of 466m year over year
View Chart On Koyfin

Quarterly XLRN EV / Sales (ntm) Data

09/202049.95
09/202048.03
09/202047.63
09/202046.18
09/202051.75
09/202048.22
09/202047.16
09/202046.89
09/202045.80
09/202044.40

Annual XLRN EV / Sales (ntm) Data

202049.95
202048.03
202047.63
202046.18
202051.75
202048.22
202047.16
202046.89
202045.80
202044.40